Title of article :
Daily Consumption of Caper Fruit Along With Atorvastatin Has Synergistic Effects in Hyperlipidemic Patients: Randomized Clinical Trial
Author/Authors :
Sardari, Saeed Department of Iranian Traditional Medicine - Shahed University , Fallahi, Faramarz Department of Cardiology Mostafa Khomeini Hospital - Shahed University , Emadi, Fatemeh Department of Iranian Traditional Medicine - Shahed University , Davati, Ali Department of Iranian Traditional Medicine - Shahed University , Khavasi, Narjes Department of Iranian Traditional Medicine - Shahed University , Gholamifesharaki, Mohammad Department of Persian Medicine - School of Medicine - Zanjan University of Medical Sciences , Esmaeili, Saeid Department of Biostatistics - Tarbiat Modares University
Pages :
7
From page :
1
To page :
7
Abstract :
Background: Dyslipidemia leads to micro- and macro-vascular complications. Atorvastatin is the main therapeutic drug used for dyslipidemia, but it causes side effects such as new type 2 diabetes mellitus onset and elevation of liver enzymes. Herbs may be useful in reducing atorvastatin doses. Caper fruit, an herbal drug in Persian Medicine, has hypolipidemic effects. Hence, the effect of atorvastatin therapy with and without daily caper fruit pickle (CFP) consumption was assessed on hyperlipidemia. Materials and Methods: In this single-blinded, randomized, controlled trial, 60 hyperlipidemic patients were allocated in two groups and treated with 10 mg atorvastatin plus 40-50 g CFP (A10+CFP) or atorvastatin alone (A10) for eight weeks. Biochemical parameters were measured at baseline, 4, and eight weeks of the intervention. One-way repeated measure ANOVA and mixed ANOVA were used to measure the effect of the two treatments and the interaction between the type of treatment and time on lipid profile. Results: Serum total cholesterol and low-density lipoprotein cholesterol (LDL-C) were significantly decreased in the A10+CFP group compared with the A10 group (P<0.001 and P<0.001, respectively) from baseline up to the week 8. At week 4, mean changes of LDL-C was significantly higher in the A10+CFP compared with the A10 (P=0.01). Adjusting for the baseline variables, the mean difference of alanine aminotransferase (P<0.01) and triglyceride (P=0.003) were significantly higher in the A10+CFP group at the end. Conclusion: This study reports that the intake of CFP along with atorvastatin daily may have synergistic effects which improve the lipid profile in hyperlipidemic patients
Keywords :
Caper , Atorvastatin , Lipid Profile
Journal title :
Galen Medical Journal (GMJ)
Serial Year :
2019
Record number :
2500598
Link To Document :
بازگشت